Boeing Secures $8.6 Billion Pentagon Contract for F-15 Jets for Israel 
Meta Acquires AI Startup Manus to Expand Advanced AI Capabilities Across Platforms 
ByteDance Plans Massive AI Chip Spending Boost as Nvidia Demand Grows in China 
Oracle Stock Surges After Hours on TikTok Deal Optimism and OpenAI Fundraising Buzz 
Apple Opens iPhone to Alternative App Stores in Japan Under New Competition Law 
Nvidia to Acquire Groq in $20 Billion Deal to Boost AI Chip Dominance 
Texas App Store Age Verification Law Blocked by Federal Judge in First Amendment Ruling 
FTC Praises Instacart for Ending AI Pricing Tests After $60M Settlement 
TikTok U.S. Deal Advances as ByteDance Signs Binding Joint Venture Agreement 
Boeing Secures Major $2.7 Billion U.S. Military Contract for Apache Helicopter Support 
Republicans Raise National Security Concerns Over Intel’s Testing of China-Linked Chipmaking Tools 
Jared Isaacman Confirmed as NASA Administrator, Becomes 15th Leader of U.S. Space Agency 
Moore Threads Unveils New GPUs, Fuels Optimism Around China’s AI Chip Ambitions 
Star Entertainment Leadership Shake-Up Deepens as CFO and COO Exit Amid Ongoing Restructuring 
Samsung Electronics Secures Annual U.S. Licence for China Chip Equipment Imports in 2026 
Vanda Pharmaceuticals Wins FDA Approval for New Motion Sickness Drug After Four Decades 
Micron Technology Forecasts Surge in Revenue and Earnings on AI-Driven Memory Demand 
Elon Musk’s brain-computer interface startup Neuralink is preparing for a major expansion, with plans to begin high-volume production of its brain implant devices and transition to fully automated surgical procedures in 2026. The announcement was made by Musk in a post on X, signaling a significant step forward for the neurotechnology company that aims to merge the human brain with computers.
Neuralink’s brain implant is designed to help people with serious neurological conditions, particularly those with spinal cord injuries or severe paralysis. The device enables users to control digital interfaces directly through thought. According to previously shared demonstrations, the first human patient implanted with the Neuralink chip has been able to play video games, browse the internet, post on social media, and move a cursor on a laptop without physical movement. These early results have generated global interest in brain-computer interface technology and its future applications.
Although Musk’s post outlined ambitious production and automation goals, Neuralink did not immediately respond to a request for comment from Reuters. The company has, however, steadily progressed through regulatory and clinical milestones. After initially facing rejection from the U.S. Food and Drug Administration in 2022 due to safety concerns, Neuralink addressed the issues and received approval to begin human trials in 2024. This approval marked a critical turning point for the company and the broader brain implant industry.
In September, Neuralink disclosed that 12 people worldwide with severe paralysis had received its brain implants. These patients were reportedly using the technology to control both digital and physical tools using only their thoughts, highlighting the real-world potential of Neuralink’s technology. The company’s progress has also attracted strong investor confidence. In June, Neuralink secured $650 million in a funding round, providing substantial capital to scale production, refine its surgical robotics, and expand clinical trials.
If successful, Neuralink’s move toward automated brain surgery and mass production could accelerate the adoption of brain-computer interfaces and reshape treatment options for neurological disorders, positioning the company at the forefront of the rapidly evolving neurotechnology sector.
